ICCC - Immucell Corp.
IEX Last Trade
3.74
-0.070 -1.872%
Share volume: 39,701
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.81
-0.07
-1.84%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-21 | 2023-03-29 | 2023-05-11 | 2023-08-10 | 2023-11-13 | 2024-04-01 | 2024-05-14 | |
| Total revenue | 3.861 M | 4.796 M | 3.911 M | 3.447 M | 3.533 M | 5.397 M | 5.096 M | 7.258 M | |
| Cost of revenue | 2.154 M | 2.950 M | 2.919 M | 3.146 M | 2.489 M | 4.130 M | 3.838 M | 4.962 M | |
| Gross profit | 1.707 M | 1.846 M | 992.177 K | 300.775 K | 1.044 M | 1.267 M | 1.258 M | 2.295 M | |
| 8.13% | -46.25% | -69.69% | 247.07% | 21.36% | -0.72% | 82.50% | |||
| Operating expenses | 2.326 M | 2.463 M | 2.626 M | 2.557 M | 2.348 M | 2.451 M | 2.261 M | 2.595 M | |
| Selling general and admin | 1.188 M | 1.193 M | 1.577 M | 1.446 M | 1.249 M | 1.332 M | 1.195 M | 1.333 M | |
| Research and development | 1.139 M | 1.270 M | 1.049 M | 1.110 M | 1.100 M | 1.118 M | 1.066 M | 1.263 M | |
| Total expenses | 4.480 M | 5.413 M | 5.545 M | 5.703 M | 4.837 M | 6.581 M | 6.099 M | 7.558 M | |
| 20.81% | 2.44% | 2.85% | -15.18% | 36.04% | -7.31% | 23.91% | |||
| Operating income | -619.007 K | -616.790 K | -1.634 M | -2.256 M | -1.304 M | -1.184 M | -1.003 M | -300.052 K | |
| Ebit | -619.007 K | -616.790 K | -1.634 M | -2.256 M | -1.304 M | -1.184 M | -1.003 M | -300.052 K | |
| Pretax income | -683.000 K | -651.211 K | -1.666 M | -2.314 M | -1.378 M | -939.771 K | -1.138 M | -436.528 K | |
| -4.65% | 155.89% | 38.84% | -40.43% | -31.81% | 21.14% | -61.66% | |||
| Income tax | 1.148 K | 3.867 K | 1.509 K | 1.525 K | 1.525 K | 229.000 | 1.348 K | 1.340 K | |
| Net income basic | -684.148 K | -655.078 K | -1.668 M | -2.315 M | -1.380 M | -940.000 K | -1.140 M | -437.868 K | |
| 4.25% | -154.61% | -38.80% | 40.40% | 31.87% | -21.26% | 61.58% | |||
| Net income | -684.148 K | -655.078 K | -1.668 M | -2.315 M | -1.380 M | -940.000 K | -1.140 M | -437.868 K | |
| 4.25% | -154.61% | -38.80% | 40.40% | 31.87% | -21.26% | 61.58% |